Oppenheimer Asset Management Inc. purchased a new position in shares of OraSure Technologies, Inc. (NASDAQ:OSUR) in the 3rd quarter, HoldingsChannel.com reports. The institutional investor purchased 12,535 shares of the medical instruments supplier’s stock, valued at approximately $194,000.
Other hedge funds also recently bought and sold shares of the company. Point72 Asset Management L.P. acquired a new stake in shares of OraSure Technologies during the second quarter worth approximately $122,000. Cubist Systematic Strategies LLC acquired a new stake in shares of OraSure Technologies during the first quarter worth approximately $139,000. Engineers Gate Manager LP acquired a new stake in shares of OraSure Technologies during the second quarter worth approximately $197,000. Xact Kapitalforvaltning AB acquired a new stake in shares of OraSure Technologies during the second quarter worth approximately $198,000. Finally, BlueMountain Capital Management LLC acquired a new stake in shares of OraSure Technologies during the second quarter worth approximately $209,000. Institutional investors and hedge funds own 92.00% of the company’s stock.
In other news, Director Charles W. Patrick sold 8,000 shares of OraSure Technologies stock in a transaction that occurred on Monday, August 27th. The shares were sold at an average price of $16.29, for a total value of $130,320.00. Following the transaction, the director now owns 54,298 shares of the company’s stock, valued at $884,514.42. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Company insiders own 2.90% of the company’s stock.
A number of analysts have issued reports on the stock. Zacks Investment Research cut shares of OraSure Technologies from a “buy” rating to a “hold” rating in a research note on Tuesday, August 7th. Raymond James reiterated a “mkt perform” rating on shares of OraSure Technologies in a research note on Tuesday, October 23rd. Stephens cut shares of OraSure Technologies from an “overweight” rating to an “equal weight” rating in a research note on Monday, July 16th. BidaskClub cut shares of OraSure Technologies from a “sell” rating to a “strong sell” rating in a research note on Thursday, September 20th. Finally, TheStreet upgraded shares of OraSure Technologies from a “c+” rating to a “b” rating in a research note on Thursday, August 9th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $20.50.
NASDAQ OSUR opened at $13.01 on Friday. The company has a market capitalization of $900.47 million, a price-to-earnings ratio of 50.76, a price-to-earnings-growth ratio of 3.46 and a beta of 1.52. OraSure Technologies, Inc. has a 12-month low of $12.50 and a 12-month high of $22.22.
OraSure Technologies (NASDAQ:OSUR) last posted its earnings results on Wednesday, November 7th. The medical instruments supplier reported $0.13 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.11 by $0.02. The firm had revenue of $45.90 million during the quarter, compared to analysts’ expectations of $44.50 million. OraSure Technologies had a net margin of 9.49% and a return on equity of 6.68%. The company’s revenue was up 8.5% compared to the same quarter last year. During the same period in the previous year, the company earned $0.09 earnings per share. Equities research analysts predict that OraSure Technologies, Inc. will post 0.34 EPS for the current fiscal year.
OraSure Technologies Company Profile
OraSure Technologies, Inc, together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, OSUR and DNAG. The company also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests.
Featured Article: Liquidity
Want to see what other hedge funds are holding OSUR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OraSure Technologies, Inc. (NASDAQ:OSUR).
Receive News & Ratings for OraSure Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies and related companies with MarketBeat.com's FREE daily email newsletter.